Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19984 | 26226097 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. | 2015 | Details |
| A19987 | 26224399 | Expert Rev Gastroenterol Hepatol | Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. | 2015 | Details |
| A19998 | 26215420 | Biomed Khim | [Intensity of apoptotic processes, aconitate hydratase activity and citrate level in patients with type 2 diabetes mellitus complicated steatohepatitis under application of epifamin at basic therapy]. | 2016 | Details |
| A19999 | 26215323 | BMC Gastroenterol | Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. | 2015 | Details |
| A20000 | 26215259 | Nat Rev Endocrinol | Physiological and pathophysiological roles of NAMPT and NAD metabolism. | 2015 | Details |
| A20032 | 26198953 | Nan Fang Yi Ke Da Xue Xue Bao | [Association between polymorphisms in pigment epithelium-derived factor gene promoter region and non-alcoholic fatty liver disease in type 2 diabetes mellitus]. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20038 | 26195184 | Expert Opin Biol Ther | Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study. | 2015 | Details |
| A20048 | 26191473 | Springerplus | Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20065 | 26182253 | Dtsch Med Wochenschr | [Non-alcoholic fatty liver disease (NAFLD)]. | 2015 | Details |
| A20070 | 26176710 | Liver Int | The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. | 2015 | Details |
| A20074 | 26174761 | Arab J Gastroenterol | Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit? | 2015 | Details |
| A20076 | 26173075 | Menopause | Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. | 2016 | Details |
| A20086 | 26167390 | J Clin Imaging Sci | The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. | 2015 | Details |
| A20087 | 26167252 | World J Hepatol | Non-alcohol fatty liver disease in Asia: Prevention and planning. | 2015 | Details |
| A20090 | 26166101 | Medicine (Baltimore) | Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20095 | 26157039 | Ultrason Imaging | Doppler Tissue Evaluation of Atrial Conduction Properties in Patients With Non-alcoholic Fatty-liver Disease. | 2015 | Details |
| A20096 | 26156527 | Diabetes Care | Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes. | 2015 | Details |
| A20099 | 26155623 | Ter Arkh | [Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20112 | 26147768 | Hepatol Res | Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus. | 2015 | Details |
| A20113 | 26147696 | Hepatol Res | Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway. | 2015 | Details |
| A20122 | 26140084 | World J Hepatol | Systematic review: Preventive and therapeutic applications of metformin in liver disease. | 2015 | Details |
| A20145 | 26125952 | PLoS One | Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. | 2015 | Details |
| A20148 | 26123841 | Liver Int | Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. | 2015 | Details |
| A20156 | 26118770 | Recent Pat Food Nutr Agric | Soybean and Processed Soy Foods Ingredients, and Their Role in Cardiometabolic Risk Prevention. | 2015 | Details |
| A20168 | 26114083 | Curr Hepatol Rep | PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE. | 2015 | Details |
| A20174 | 26111358 | J Gastroenterol Hepatol | Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A20181 | 26102213 | Nutrients | Hepatic Steatosis as a Marker of Metabolic Dysfunction. | 2015 | Details |
| A20183 | 26100857 | Nat Commun | A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism. | 2015 | Details |
| A20221 | 26078558 | World J Gastroenterol | Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. | 2015 | Details |
| A20222 | 26078557 | World J Gastroenterol | What are the effects of proton pump inhibitors on the small intestine? | 2015 | Details |
| A20223 | 26078246 | Asia Pac J Clin Nutr | Low physical activity and energy dense Malaysian foods are associated with non-alcoholic fatty liver disease in centrally obese but not in non-centrally obese patients with diabetes mellitus. | 2015 | Details |
| A20233 | 26073454 | Prog Lipid Res | Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. | 2015 | Details |
| A20234 | 26072069 | J Huazhong Univ Sci Technolog Med Sci | Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease. | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20243 | 26066519 | Toxicology | A Northern contaminant mixture impairs pancreas function in obese and lean JCR rats and inhibits insulin secretion in MIN6 cells. | 2015 | Details |
| A20249 | 26064107 | Int J Endocrinol | Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20257 | 26060181 | J Bioenerg Biomembr | Protective effects of dietary avocado oil on impaired electron transport chain function and exacerbated oxidative stress in liver mitochondria from diabetic rats. | 2015 | Details |
| A20259 | 26058864 | Am J Physiol Endocrinol Metab | Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. | 2015 | Details |
| A20263 | 26056853 | Toxicol Mech Methods | Perfluorononanoic acid disturbed the metabolism of lipid in the liver of streptozotocin-induced diabetic rats. | 2015 | Details |
| A20278 | 26049073 | Semin Thromb Hemost | Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20281 | 26047682 | Diabetes Res Clin Pract | Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES). | 2015 | Details |
| A20282 | 26046667 | Eur J Clin Invest | Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38). | 2015 | Details |
| A20291 | 26043290 | Eur J Gastroenterol Hepatol | Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20293 | 26042596 | PLoS One | Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes. | 2015 | Details |
| A20341 | 26021488 | Diabetologia | Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial. | 2015 | Details |
| A20362 | 26016715 | Diabetes | Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20367 | 26011302 | Metab Syndr Relat Disord | Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20369 | 26008803 | Diab Vasc Dis Res | Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes. | 2015 | Details |
| A20373 | 26005676 | Hepatobiliary Surg Nutr | Fatty liver disease in diabetes mellitus. | 2015 | Details |
| A20392 | 25994191 | Eur Radiol | Cost-utility analysis of nonalcoholic steatohepatitis screening. | 2015 | Details |
| A20393 | 25994073 | Diabetologia | Incretin-based therapies: where will we be 50 years from now? | 2015 | Details |
| A20396 | 25993652 | PLoS One | S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. | 2015 | Details |
| A20414 | 25982699 | Metabolism | Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. | 2015 | Details |
| A20415 | 25981893 | Diabet Med | Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis. | 2015 | Details |
| A20416 | 25981325 | Diabetes Res Clin Pract | Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver. | 2015 | Details |
| A20419 | 25977117 | Liver Int | Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. | 2015 | Details |
| A20420 | 25976242 | Acta Diabetol | GCKR polymorphism influences liver fat content in patients with type 2 diabetes. | 2015 | Details |
| A20423 | 25974699 | Annu Rev Nutr | Health Benefits of Long-Term Weight-Loss Maintenance. | 2015 | Details |
| A20432 | 25969716 | J Diabetes Investig | Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes. | 2014 | Details |
| A20437 | 25966055 | Genet Mol Res | Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease. | 2015 | Details |
| A20440 | 25961735 | PLoS One | Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients. | 2015 | Details |
| A20441 | 25961686 | Front Biosci (Schol Ed) | Epigenetic crosstalk: a molecular language in human metabolic disorders. | 2015 | Details |
| A20442 | 25961500 | Sci Rep | Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20448 | 25957758 | Metabolism | Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2015 | Details |
| A20457 | 25948763 | Acta Med Indones | Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH). | 2015 | Details |
| A20458 | 25948673 | Am J Clin Nutr | Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease. | 2015 | Details |
| A20461 | 25947379 | J Biol Chem | 1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma. | 2015 | Details |
| A20463 | 25945652 | Cell Cycle | Modulation of insulin degrading enzyme activity and liver cell proliferation. | 2015 | Details |
| A20465 | 25945002 | World J Gastroenterol | Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. | 2015 | Details |
| A20468 | 25941433 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. | 2015 | Details |
| A20471 | 25940690 | Food Funct | Salicylic acid elicitation during cultivation of the peppermint plant improves anti-diabetic effects of its infusions. | 2015 | Details |
| A20477 | 25937862 | World J Hepatol | Non-alcoholic fatty liver disease: The diagnosis and management. | 2015 | Details |
| A20479 | 25935633 | Gastroenterology | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20497 | 25921668 | Clin Liver Dis | Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. | 2015 | Details |
| A20502 | 25920090 | J Hepatol | NAFLD: a multisystem disease. | 2015 | Details |
| A20503 | 25919774 | Eur J Gastroenterol Hepatol | Bariatric surgery and nonalcoholic fatty liver disease. | 2015 | Details |
| A20531 | 25906757 | J Endocrinol Invest | 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. | 2015 | Details |
| A20532 | 25906661 | Lik Sprava | [Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transaminases level]. | 2015 | Details |
| A20534 | 25906652 | Lik Sprava | [State of intestinal microbiota in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2015 | Details |
| A20547 | 25894944 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. | 2015 | Details |
| A20550 | 25892963 | Int J Biol Sci | ER stress and autophagy dysfunction contribute to fatty liver in diabetic mice. | 2015 | Details |
| A20552 | 25892859 | World J Gastroenterol | Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. | 2015 | Details |
| A20559 | 25887357 | Diabetes Care | Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. | 2015 | Details |
| A20561 | 25885947 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2015 | Details |
| A20562 | 25884354 | BMC Cancer | Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma. | 2015 | Details |
| A20568 | 25879672 | Liver Int | Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. | 2015 | Details |
| A20569 | 25877813 | Diabetes Care | Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. | 2015 | Details |
| A20571 | 25877002 | Scand J Gastroenterol | The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus. | 2015 | Details |
| A20575 | 25876566 | Intern Med | Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan. | 2015 | Details |
| A20582 | 25873639 | Gut | Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. | 2015 | Details |
| A20615 | 25850006 | Cardiovasc Diabetol | Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients. | 2015 | Details |
| A20618 | 25849783 | Cardiovasc Diabetol | Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control. | 2015 | Details |
| A20624 | 25847730 | Liver Int | Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. | 2015 | Details |
| A20638 | 25840922 | Dig Dis Sci | Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. | 2015 | Details |
| A20644 | 25836944 | Diabetes Res Clin Pract | Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. | 2015 | Details |
| A20645 | 25835982 | Obes Surg | Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. | 2015 | Details |
| A20651 | 25832152 | Med J Aust | The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes. | 2015 | Details |
| A20653 | 25830307 | Ann Gastroenterol | Metabolic and cardiovascular complications in the liver transplant recipient. | 2020 | Details |